Surgical Pathology Cancer Case
Summary
URINARY BLADDER, URETER, RENAL PELVIS:
Report
Surgical Pathology Cancer Case Summary
URETER: Resection
MACROSCOPIC (check
all that apply)
___ Right ureter
___ Left ureter
TUMOR SIZE: ___ x ___ x ___ cm*
TUMOR CONFIGURATION*
___ Papillary
___ Solid/nodule
___ Ulcerated
___ Flat
___ Indeterminate
MICROSCOPIC (check all
that apply)
HISTOLOGIC
TYPE
___ Urothelial (transitional cell) papilloma (WHO/ISUP,
1998; WHO, 1973)
___ Urothelial (transitional cell) papilloma, inverted type
___
Squamous cell papilloma
___
Papillary urothelial (transitional cell) neoplasm, low malignant potential
(WHO/ISUP 1998)/ grade I (WHO, 1973)
___ Urothelial (transitional cell) carcinoma in situ
___ Urothelial (transitional cell) carcinoma
___ Urothelial (transitional cell) carcinoma with the
following:
___
Squamous differentiation
___ Glandular
differentiation
___ Variant histology
(specify)
___
Squamous cell carcinoma
___ Typical
___ Variant
histology (specify)
___ Adenocarcinoma
___ Typical
___ Variant
histology (specify)
___ Small cell carcinoma
___ Undifferentiated carcinoma (specify)
___ Carcinoma, mixed cell type (check all that apply)
___ Urothelial (transitional cell)
___ Squamous cell
___ Adenocarcinoma
___ Small cell carcinoma
___ Other (specify)
HISTOLOGIC
GRADE
___ For urothelial carcinoma (WHO/ISUP, 1998)
___ Low
grade
___ High
grade
___ For adenocarcinoma and squamous carcinoma
___
GX: Cannot be
assessed
___ G1: Well differentiated
___ G2:
Moderately differentiated
___ G3-4:
Poorly differentiated/undifferentiated
___
TX: Cannot be assessed
___ T0: No evidence of primary tumor
___ Ta: Papillary noninvasive papillary carcinoma
___ Tis: Carcinoma in situ
___ T1: Tumor invades subepithelial connective tissue
___ T2: Tumor invades the muscularis
___ T3: Tumor invades beyond muscularis into periureteric
fat
___ T4: Tumor invades adjacent organs, or through the kidney
into the perinephric fat
MARGINS
___ Margins uninvolved by tumor
Distance of tumor
from closest margin: __ cm
(Specify margin (s):
________________)
___ Margin(s) involved by tumor
___ Deep radial periureteral margin (soft tissue)
___ Distal ureteral margin/bladder cuff margin
___ Renal pelvic margin
___ Bladder cuff margin
___ Other(s) (specify: ____________________)
___ Absent
___ Present
___ Indeterminate (see comment)
___ NX: Cannot be assessed
___ N0: No regional lymph node metastasis
Number examined: ___
___ N1: Metastasis in a single lymph node, 2 cm or less in
greatest dimension
Number examined: ___
___ N2:
Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in
greatest dimension, or multiple lymph nodes, none more than 5 cm in greatest
dimension
Number examined: ___
Number involved: ___
___ N3: Metastasis in a lymph node more than 5 cm in greatest
dimension
Number examined: ___
Total number involved
(any size): ___
___ MX: Cannot be assessed
___ M0: No distant metastasis
___ M1: Distant metastasis (site(s):_________
_____________________________________)
ADDITIONAL PATHOLOGIC FINDINGS*
___ Urothelial dysplasia (low grade intraurothelial
neoplasia)
___ Focal
___ Multifocal
___ Inflammation/regenerative changes
___ Therapy related changes
___ Cystitis cystica glandularis
___ Keratinizing squamous metaplasia
___ Intestinal metaplasia
___ Other (specify):
___________________________________________
___________________________________________
___________________________________________
___________________________________________